<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Clin Microbiol Antimicrob</journal-id>
      <journal-title>Annals of Clinical Microbiology and Antimicrobials</journal-title>
      <issn pub-type="epub">1476-0711</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18513394</article-id>
      <article-id pub-id-type="pmc">2430584</article-id>
      <article-id pub-id-type="publisher-id">1476-0711-7-12</article-id>
      <article-id pub-id-type="doi">10.1186/1476-0711-7-12</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Imported PER-1 producing <italic>Pseudomonas aeruginosa</italic>, PER-1 producing <italic>Acinetobacter baumanii </italic>and VIM-2-producing <italic>Pseudomonas aeruginosa </italic>strains in Hungary</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" equal-contrib="yes" corresp="yes" contrib-type="author">
          <name>
            <surname>Szab&#xF3;</surname>
            <given-names>Dora</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>szabdor@net.sote.hu</email>
        </contrib>
        <contrib id="A2" equal-contrib="yes" contrib-type="author">
          <name>
            <surname>Szentandr&#xE1;ssy</surname>
            <given-names>Julia</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>mikrobiologia@mhkhk.hu</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Juh&#xE1;sz</surname>
            <given-names>Zsuzsa</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>dr.juhaszzs@freemail.hu</email>
        </contrib>
        <contrib id="A4" contrib-type="author">
          <name>
            <surname>Katona</surname>
            <given-names>Katalin</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>katalinkatona@freemail.hu</email>
        </contrib>
        <contrib id="A5" contrib-type="author">
          <name>
            <surname>Nagy</surname>
            <given-names>K&#xE1;roly</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>nagykar@net.sote.hu</email>
        </contrib>
        <contrib id="A6" contrib-type="author">
          <name>
            <surname>R&#xF3;kusz</surname>
            <given-names>L&#xE1;szl&#xF3;</given-names>
          </name>
          <xref ref-type="aff" rid="I4">4</xref>
          <email>rokusz@t-online.hu</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Institute of Medical Microbiology, Semmelweis University, Budapest, H-1089, Nagyv&#xE1;rad t&#xE9;r 4., Hungary</aff>
      <aff id="I2"><label>2</label>Department of Microbiology, State Health Center, Budapest, H-1134 R&#xF3;bert K&#xE1;roly krt. 44., Hungary</aff>
      <aff id="I3"><label>3</label>Burn Unit, State Health Center, Budapest, H-1134 R&#xF3;bert K&#xE1;roly krt. 44., Hungary</aff>
      <aff id="I4"><label>4</label>First Department of Medicine, State Health Center, Budapest, H-1134 R&#xF3;bert K&#xE1;roly krt. 44., Hungary</aff>
      <pub-date pub-type="collection">
        <year>2008</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>5</month>
        <year>2008</year>
      </pub-date>
      <volume>7</volume>
      <fpage>12</fpage>
      <lpage>12</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.ann-clinmicrob.com/content/7/1/12"/>
      <history>
        <date date-type="received">
          <day>22</day>
          <month>2</month>
          <year>2008</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>5</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2008 Szab&#xF3; et al; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2008</copyright-year>
        <copyright-holder>Szab&#xF3; et al; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
          <!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Szab&#x000f3;
               Dora
               
               
               szabdor@net.sote.hu
            </dc:author><dc:title>
            Imported PER-1 producing Pseudomonas aeruginosa, PER-1 producing Acinetobacter baumanii and VIM-2-producing Pseudomonas aeruginosa strains in Hungary
         </dc:title><dc:date>2008</dc:date><dcterms:bibliographicCitation>Annals of Clinical Microbiology and Antimicrobials 7(1): 12-. (2008)</dcterms:bibliographicCitation><dc:identifier type="sici">1476-0711(2008)7:1&#x0003c;12&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1476-0711</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>-->
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Introduction</title>
          <p><italic>Pseudomonas aeruginosa </italic>and <italic>Acinetobacter baumanii </italic>are important nosocomial pathogens with wide intrinsic resistance. However, due to the dissemination of the acquired resistance mechanisms, such as extended-spectrum beta-lactamase (ESBL) and metallo beta-lactamase (MBL) production, multidrug resistant strains have been isolated more often.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>We report a case of a Hungarian tourist, who was initially hospitalized in Egypt and later transferred to Hungary. On the day of admission PER-1-producing <italic>P. aeruginosa</italic>, PER-1 producing <italic>A. baumannii</italic>, SHV-5-producing <italic>Klebsiella pneumoniae </italic>and VIM-2-producing <italic>P. aeruginosa </italic>isolates were subcultured from the patient's samples in Hungary. Comparing the pulsed-field gel electrophoresis (PFGE) patterns of the <italic>P. aeruginosa </italic>strains from the patient to the <italic>P. aeruginosa </italic>strains occurring in this hospital, we can state that the PER-1-producing <italic>P. aeruginosa </italic>and VIM-2-producing <italic>P. aeruginosa </italic>had external origin.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>This is the first report of PER-1-producing <italic>P. aeruginosa</italic>,and PER-1-producing <italic>A. baumanii s</italic>trains in Hungary. This case highlights the importance of spreading of the beta-lactamase-mediated resistance mechanisms between countries and continents, showing the importance of careful screening and the isolation of patients arriving from a different country.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p><italic>Pseudomonas aeruginosa </italic>and <italic>Acinetobacter baumanii </italic>are very important nosocomial pathogens mainly in intensive care units, being responsible for various types of infections with more and more limited therapeutic options [<xref ref-type="bibr" rid="B1">1</xref>].</p>
      <p>The <italic>P. aeruginosa </italic>have significant intrinsic resistance to antibiotics [<xref ref-type="bibr" rid="B2">2</xref>]. Therefore, the antipseudomonal beta-lactams such as ticarcillin, piperacillin, ceftazidime, cefepime, aztreonam, and the carbapenems have an important therapeutic value. Three mechanisms of beta-lactam resistance are predominant: production of beta-lactamases, loss of outer membrane proteins and up-regulation of efflux pumps. Most strains of <italic>P. aeruginosa </italic>which are resistant to third-generation cephalosporins produce a chromosomally mediated molecular class C beta-lactamase, the AmpC enzyme [<xref ref-type="bibr" rid="B2">2</xref>]. However, acquired beta-lactamases encoded by mobile genetic elements are important resistance mechanism in <italic>P. aeruginosa </italic>and in <italic>Acinetobacter </italic>spp. as well. Acquired resistance to beta-lactams can lead to therapeutic failure, especially when it is associated with resistance to other classes of drugs, such as aminoglycosides and fluoroquinolones. Among these enzymes acquired, PER (<italic>Pseudomonas </italic>extended resistance), a class A extended-spectrum beta-lactamase (ESBL), occurring less frequently has clinical importance by conferring resistance to oxyimino beta-lactams [<xref ref-type="bibr" rid="B3">3</xref>]. Poor outcome as a result of infection caused by PER-1 producers has been reported [<xref ref-type="bibr" rid="B4">4</xref>]. The also acquired metallo beta-lactamases (MBLs) of molecular class B can cause resistance to all beta-lactams except monobactam. The genes of MBLs are usually part of class I integron together with gene cassettes encoding resistance genes. Several types of MBL enzymes have been identified in <italic>P. aeruginosa </italic>among which the VIM-type enzymes appear to be the most prevalent [<xref ref-type="bibr" rid="B5">5</xref>].</p>
      <p>Here we report the first detection of PER-producing <italic>P. aeruginosa</italic>, <italic>A. baumannii </italic>isolates and VIM-producing <italic>P. aeruginosa </italic>in Hungary from a patient, who was hospitalized in Egypt and transferred to Hungary. This work illustrates the dissemination of bacteria carrying PER-type ESBL and VIM-type MBL enzymes.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>In April, 2006 a 53-year-old Hungarian tourist was involved in a severe terror-attack in Egypt. He was initially hospitalized because of his burn, mechanical injuries and sepsis syndrome in Egypt. Five days later he was transferred in comatose, hypoxic and hypothermic condition to the Burn Unit of State Health Center, Budapest, Hungary. On the day of admission, bacterial cultures taken from burn wound. Based on the different colony morphology and antibiotic susceptibility patterns three different <italic>P. aeruginosa </italic>strains &#x2013; an ESBL-producing <italic>P. aeruginosa </italic>(PA1), an imipenem-resistant <italic>P. aeruginosa </italic>(PA2), an MBL-producing <italic>P. aeruignosa </italic>(PA3), were observed and furthermore ESBL-producing <italic>Klebsiella pneumoniae </italic>(ESBL-KP), methicillin-resistant <italic>Staphylococcus aureus </italic>(MRSA) and <italic>Enterococcus faecalis </italic>(EF) were isolated. Next day ESBL-producing <italic>A. baumanii </italic>(ESBL-AB) and PA2 were cultured from the patient's canul. During his hospitalization from his nose PA1, ESBL-AB, ESBL-KP, MRSA, from his throat PA1, ESBL-AB, ESBL-KP, from his trachea PA3, ESBL-AB, ESBL.KP,-MRSA and from his wound PA1, PA3, ESBL-AB, ESBL-KP, MRSA and EF were isolated. Blood cultures were taken nine occasions and PA1, ESBL-KP, MRSA and EF were subcultured. The patient received adequate supportive treatment and empirically cefepime, subsequently meropenem and vancomycin were administered intravenously at high dosage. The aminoglycosides were synergy resistant. On the 8<sup>th </sup>day of the hospitalization in Hungary the patient died.</p>
      <p>The isolates were identified by VITEK 2 (BioM&#xE9;rieux, Marcy l'Etoile, France). On a routine antibiogram synergy was observed between amoxycillin/clavulanic acid and cefepime or ceftazidime disks <bold>(</bold>Oxoid, Basingstoke, Hampshire, United Kingdom) in <italic>K. pneumoniae </italic>and in <italic>A. baumanii </italic>strains but no synergy was observed in <italic>P. aeruginosa </italic>strains. The minimum inhibitory concentrations (MICs) of the antimicrobial agents were determined by E-test (AB Biodisk, Solna, Sweden) and by using the interpretative criteria of the Clinical and Laboratory Standards Institute [<xref ref-type="bibr" rid="B6">6</xref>]. Pulsed-field gel electrophoresis (PFGE) of the <italic>SpeI</italic>-digested (New England Biolab, Beverly, MA) genomic DNA of <italic>P. aeruginosa </italic>was performed and analyzed as described previously [<xref ref-type="bibr" rid="B7">7</xref>]. Isoelectric focusing (IEF) was performed, as described previously [<xref ref-type="bibr" rid="B8">8</xref>]. In the PCR assays primers specific to <italic>bla</italic><sub>TEM </sub>[<xref ref-type="bibr" rid="B9">9</xref>], <italic>bla</italic><sub>SHV </sub>[<xref ref-type="bibr" rid="B9">9</xref>], <italic>bla</italic><sub>PER </sub>[<xref ref-type="bibr" rid="B10">10</xref>], <italic>bla</italic><sub>OXAs </sub>[<xref ref-type="bibr" rid="B11">11</xref>], <italic>bla</italic><sub>IMP</sub>, <italic>bla</italic><sub>VIM </sub>and <italic>bla</italic><sub>classI </sub>genes [<xref ref-type="bibr" rid="B12">12</xref>] were used. The nucleotide sequences were determined using the ABI 3100 Genetic Analyzers (Applied Biosystems, Foster City, CA). Sequences were analyzed using NCBI BLAST search.</p>
      <p>Three different antibiotic susceptibility patterns were observed in <italic>P. aeruginosa </italic>strains isolated from the patient on the day of admission (Table <xref ref-type="table" rid="T1">1</xref>). All of them were resistant to cephalosporins. The PA1 <italic>P. aeruginosa </italic>strain was sensitive only to carbapenems, the other <italic>P. aeruginosa </italic>strain (PA2) was sensitive only to meropenem and both PA1 and PA2 were resistant to all the other tested antibiotics. The third <italic>P. aeruginosa </italic>(PA3) strain was sensitive to aztreonam and netilmicin and resistant to the all cephalosporins and carbepenems. However, the imipenem MIC value decreased in the presence of EDTA from &gt; 256 to 12 &#x3BC;g/ml suggesting the presence of an MBL enzyme. The <italic>A. baumanii </italic>isolate was resistant to all cephalosporins and aztreonam, but the ceftazidime and cefotaxime MIC values decreased in the presence of clavulanic acid suggesting the presence of an ESBL enzyme. The <italic>K. pneumoniae </italic>strain had also ESBL phenotype based on the MIC values and it was sensitive to carbapenems, amikacin and ciprofloxacin as well.</p>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>The antibiotic susceptibility of <italic>P. aeruginosa</italic>, <italic>A. baumanii </italic>and <italic>K. pneumoniae </italic>strains.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <td align="left">Antimicrobial agents</td>
              <td align="center" colspan="5">MIC values (&#x3BC;g/ml)</td>
            </tr>
            <tr>
              <td/>
              <td colspan="5">
                <hr/>
              </td>
            </tr>
            <tr>
              <td/>
              <td align="center"><italic>P. aeruginosa </italic>(PA1)</td>
              <td align="center"><italic>P. aeruginosa </italic>(PA2)</td>
              <td align="center"><italic>P. aeruginosa </italic>(PA3)</td>
              <td align="center">
                <italic>A. baumanii</italic>
              </td>
              <td align="center">
                <italic>K. pneumoniae</italic>
              </td>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">Ceftazidime</td>
              <td align="center">&gt; 256</td>
              <td align="center">&gt; 256</td>
              <td align="center">&gt; 256</td>
              <td align="center">&gt; 256</td>
              <td align="center">&gt; 256</td>
            </tr>
            <tr>
              <td align="left">Ceftazidime/clavulanic acid</td>
              <td align="center">&gt; 4</td>
              <td align="center">&gt; 4</td>
              <td align="center">&gt; 4</td>
              <td align="center">&lt; 0.64</td>
              <td align="center">3</td>
            </tr>
            <tr>
              <td align="left">Cefotaxime</td>
              <td align="center">&gt; 32</td>
              <td align="center">&gt; 32</td>
              <td align="center">&gt; 32</td>
              <td align="center">&gt; 32</td>
              <td align="center">&gt; 32</td>
            </tr>
            <tr>
              <td align="left">Cefotaxime/clavulanic acid</td>
              <td align="center">&gt; 1</td>
              <td align="center">&gt; 1</td>
              <td align="center">&gt; 1</td>
              <td align="center">0.23</td>
              <td align="center">0.38</td>
            </tr>
            <tr>
              <td align="left">Ceftriaxone</td>
              <td align="center">&gt; 256</td>
              <td align="center">&gt; 256</td>
              <td align="center">&gt; 256</td>
              <td align="center">&gt; 256</td>
              <td align="center">&gt; 256</td>
            </tr>
            <tr>
              <td align="left">Piperacillin/tazobactam</td>
              <td align="center">&gt; 256</td>
              <td align="center">&gt; 256</td>
              <td align="center">&gt; 256</td>
              <td align="center">&gt; 256</td>
              <td align="center">&gt; 256</td>
            </tr>
            <tr>
              <td align="left">Cefepime</td>
              <td align="center">&gt; 32</td>
              <td align="center">&gt; 32</td>
              <td align="center">&gt; 32</td>
              <td align="center">&gt; 32</td>
              <td align="center">&gt; 32</td>
            </tr>
            <tr>
              <td align="left">Aztreonam</td>
              <td align="center">&gt; 64</td>
              <td align="center">32</td>
              <td align="center">8</td>
              <td align="center">&gt; 64</td>
              <td align="center">&gt; 64</td>
            </tr>
            <tr>
              <td align="left">Imipenem</td>
              <td align="center">2</td>
              <td align="center">32</td>
              <td align="center">&gt; 256</td>
              <td align="center">1</td>
              <td align="center">1</td>
            </tr>
            <tr>
              <td align="left">Imipenem+EDTA</td>
              <td align="center">1.5</td>
              <td align="center">32</td>
              <td align="center">12</td>
              <td align="center">1.5</td>
              <td align="center">&lt; 1</td>
            </tr>
            <tr>
              <td align="left">Meropenem</td>
              <td align="center">0.25</td>
              <td align="center">1</td>
              <td align="center">&gt; 32</td>
              <td align="center">0.38</td>
              <td align="center">0.25</td>
            </tr>
            <tr>
              <td align="left">Amikacin</td>
              <td align="center">&gt; 256</td>
              <td align="center">6</td>
              <td align="center">&gt; 256</td>
              <td align="center">48</td>
              <td align="center">1.5</td>
            </tr>
            <tr>
              <td align="left">Gentamicin</td>
              <td align="center">16</td>
              <td align="center">&gt; 256</td>
              <td align="center">&gt; 256</td>
              <td align="center">32</td>
              <td align="center">&gt; 256</td>
            </tr>
            <tr>
              <td align="left">Netilmicin</td>
              <td align="center">&gt; 32</td>
              <td align="center">&gt; 32</td>
              <td align="center">2</td>
              <td align="center">1</td>
              <td align="center">&gt; 32</td>
            </tr>
            <tr>
              <td align="left">Tobramycin</td>
              <td align="center">&gt; 256</td>
              <td align="center">&gt; 256</td>
              <td align="center">32</td>
              <td align="center">32</td>
              <td align="center">24</td>
            </tr>
            <tr>
              <td align="left">Ciprofloxacin</td>
              <td align="center">&gt; 32</td>
              <td align="center">&gt; 32</td>
              <td align="center">&gt; 32</td>
              <td align="center">&gt; 32</td>
              <td align="center">1</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>The PCR and sequencing results are summarized in Table <xref ref-type="table" rid="T2">2</xref>. TEM-1 genes were identified in <italic>A. baumanii </italic>and <italic>K. pneumoniae</italic>. OXA genes were recognized in PA1 and PA3 strains. PER-1 genes were found in PA1 and <italic>A. baumanii </italic>isolates and SHV-5 was found in <italic>K. pneumoniae</italic>. Only the PA3 isolate harbored the VIM-2 gene. The OXA-10 and VIM-2 genes were located on the same class I integrons, as the sequencing result of class I integron showed.</p>
      <table-wrap position="float" id="T2">
        <label>Table 2</label>
        <caption>
          <p>The characteristics of the isolated Gram-negative strains.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <td/>
              <td align="center">TEM PCR</td>
              <td align="center">SHV PCR</td>
              <td align="center">PER PCR</td>
              <td align="center">OXA PCR</td>
              <td align="center">VIM PCR</td>
              <td align="center">PFGE</td>
              <td align="center">pI(s)</td>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left"><italic>P. aeruginosa </italic>(PA1)</td>
              <td align="center">negative</td>
              <td align="center">negative</td>
              <td align="center">PER-1</td>
              <td align="center">OXA-10</td>
              <td align="center">negative</td>
              <td align="center">A type</td>
              <td align="center">5.3, 6.1, 8.0</td>
            </tr>
            <tr>
              <td align="left"><italic>P. aeruginosa </italic>(PA2)</td>
              <td align="center">negative</td>
              <td align="center">negative</td>
              <td align="center">negative</td>
              <td align="center">negative</td>
              <td align="center">negative</td>
              <td align="center">B type</td>
              <td align="center">8.0</td>
            </tr>
            <tr>
              <td align="left"><italic>P. aeruginosa </italic>(PA3)</td>
              <td align="center">negative</td>
              <td align="center">negative</td>
              <td align="center">negative</td>
              <td align="center">OXA-1</td>
              <td align="center">VIM-2</td>
              <td align="center">C type</td>
              <td align="center">5.3, 7.4, 8.0</td>
            </tr>
            <tr>
              <td align="left">
                <italic>A. baumanii</italic>
              </td>
              <td align="center">TEM-1</td>
              <td align="center">negative</td>
              <td align="center">PER-1</td>
              <td align="center">negative</td>
              <td align="center">negative</td>
              <td align="center">ND</td>
              <td align="center">5.3, 5.4, &gt; 8.5</td>
            </tr>
            <tr>
              <td align="left">
                <italic>K. pneumoniae</italic>
              </td>
              <td align="center">TEM-1</td>
              <td align="center">SHV-5</td>
              <td align="center">negative</td>
              <td align="center">negative</td>
              <td align="center">negative</td>
              <td align="center">ND</td>
              <td align="center">5.4, 8.2</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>ND: not determined</p>
        </table-wrap-foot>
      </table-wrap>
      <p>According to IEF test results, all the isolates contained &#x3B2;-lactamases. Isoelectric focusing confirmed the expression of PER-1 (pI 5.3), TEM-1 (pI 5.4), OXA-1 (pI 7.4), OXA-10 (pI 6.1), SHV-5 (pI 8.2), VIM-2 (pI 5.3) and the chromosomal AmpC cephalosporinase (pI 8 or &gt; 8.5) enzymes in the different strains (Table <xref ref-type="table" rid="T2">2</xref>).</p>
      <p>The three <italic>P. aeruginosa </italic>isolates, PA1, PA2 and PA3, showed three different PFGE patterns (data not presented) suggesting that they belonged to different clones (Table <xref ref-type="table" rid="T2">2</xref>). Comparing these PFGE patterns to six other <italic>P. aeruginosa </italic>strains occurring in this Hungarian hospital during the same period, no similarity was found suggesting the external origin of PA1, PA2 and PA3.</p>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>Based on the antibiotic susceptibilities, IEF and the sequencing result we can state that the PA1 strain and the <italic>A. baumanii </italic>strain produced PER-1 ESBL enzyme. The <italic>A. baumanii </italic>strain also produced TEM-1 and the PA1 strain OXA-10 broad-spectrum &#x3B2;-lactamase. The PA2 strain produced only chromosomal AmpC cephalosporinase as suggesting that loss of OprD was responsible for the imipenem resistance. The PA3 strain produced the OXA-1 broad-spectrum &#x3B2;-lactamase and the VIM-2 MBL enzyme. The <italic>K. pneumoniae </italic>strain produced SHV-5 and TEM-1 enzyme.</p>
      <p>According to the type of ESBL enzyme produced by different bacteria species SHV- TEM- and CTX-M type ESBL-producing <italic>Klebsiella </italic>spp. and <italic>Escherichia coli </italic>strains have been isolated in Hungary so far [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>] &#x2013; while in Egypt the ESBL phenotype has been observed in <italic>K. pneumoniae </italic>and CTX-M-type ESBL in <italic>E. coli </italic>strains [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref>]. The PER-1 beta-lactamase has been considered to be significant only in Turkey for years [<xref ref-type="bibr" rid="B17">17</xref>]. However, the PER-1 beta-lactamase found mainly in <italic>P</italic>. <italic>aeruginosa </italic>has been detected in many countries such as Turkey, France, Belgium, Spain, Italy, Poland, Romania, Japan and South Korea until now [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B18">18</xref>-<xref ref-type="bibr" rid="B25">25</xref>]. The PER-1 production in <italic>Acinetobacter </italic>spp. was observed more often in Turkey and in Korea [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B27">27</xref>]. According to our knowledge this is the first report of PER-1-producing <italic>P. aeruginosa </italic>and PER-1-producing <italic>A. baumanii </italic>in Hungary and since that other strains of PER-1 producing <italic>P. aeruginosa </italic>have been isolated [<xref ref-type="bibr" rid="B28">28</xref>].</p>
      <p>Several types of MBL enzymes &#x2013; IMP-type, VIM-type, SPM-1, GIM-1, SIM-1 &#x2013; have been identified in <italic>P. aeruginosa </italic>[<xref ref-type="bibr" rid="B5">5</xref>]. The VIM enzymes are the most common in Europe [<xref ref-type="bibr" rid="B29">29</xref>]. The VIM-2 enzyme detected in this case has been previously found in several species worldwide and it seems to be the most prevalent allelic form [<xref ref-type="bibr" rid="B30">30</xref>-<xref ref-type="bibr" rid="B35">35</xref>]. In Hungary VIM-producing <italic>P. aeruginosa </italic>strains have been isolated but in Egypt MBL-producing strains have not been reported until now [<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B37">37</xref>].</p>
      <p>Furthermore the result of the PFGE analysis of the PA1, PA2 and PA3 confirms, that the three <italic>P. aeruginosa </italic>strains &#x2013; the PER-1 producing <italic>P. aeruginosa </italic>(PA1), the OprD-loss <italic>P. aeruginosa </italic>(PA2) and VIM-2-producing <italic>P. aeruginosa </italic>(PA3) strains &#x2013; had external origin and could be transferred from Egypt to Hungary. The PER-1 producing <italic>P. aeruginosa </italic>and <italic>A. baumanii </italic>strains disappeared from the hospital, no more infections have been detected with these strains since then.</p>
      <p>The emergence and subsequently spread of PER-producing and MBL-producing strains are alarming. Supposing, that these resistance mechanisms might also exist in other countries the dissemination of PER-enzyme could be more prevalent over the world, particularly due to the unsolved problem of routine screening for ESBL-production in <italic>P. aeruginosa </italic>strains. The CLSI recommendation for screening the ESBL-production in different bacteria species is uncomplete, exist just for <italic>Klebsiella </italic>spp. and <italic>Escherichia coli </italic>strains [<xref ref-type="bibr" rid="B6">6</xref>].</p>
      <p>In conclusion, this work confirms the emergence of PER-1-producing <italic>P. aeruginosa </italic>and <italic>A. baumannii </italic>isolate, VIM-2 producing <italic>P. aeruginosa </italic>strains in Hungary. Furthermore it illustrates the possibility of the inter-country and the inter-continent spread of the beta-lactamase-mediated resistance mechanisms. Our study features the intercontinental spread of antimicrobial resistance, showing the importance of careful screening and the isolation patients arriving from a different country.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>LR and ZJ provided clinical care, literature search and edited the manuscript, JS and KK identified the bacteria, performed the antibiotic susceptibility tests, DS carried out the molecular studies, characterized the bacteria and drafted the manuscript, NK drafted the manuscript. All authors read and approved the final manuscript.</p>
    </sec>
    <sec>
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient's relative for publication of this case report. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgements</title>
        <p>We thank dr. Katalin Kamotsay for her comments on the manuscript. The authors gratefully acknowledge the assistance provided by Natasa Pesti. This work was supported in part by Hungarian Scientific Research Found 48410 and by Foundation of "Budapest Bank for Budapest" 12977-2614/2007/BBB.</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gaynes</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Edwards</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Overview of nosocomial infections caused by gram-negative bacilli</article-title>
          <source>Clin Infect Dis</source>
          <year>2005</year>
          <volume>41</volume>
          <fpage>848</fpage>
          <lpage>854</lpage>
          <pub-id pub-id-type="pmid">16107985</pub-id>
          <pub-id pub-id-type="doi">10.1086/432803</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bonomo</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Szabo</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms of multidrug resistance in <italic>Acinetobacter </italic>species and <italic>Pseudomonas aeruginosa</italic></article-title>
          <source>Clin Infect Dis</source>
          <year>2006</year>
          <volume>43</volume>
          <fpage>S49</fpage>
          <lpage>56</lpage>
          <pub-id pub-id-type="pmid">16894515</pub-id>
          <pub-id pub-id-type="doi">10.1086/504477</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nordmann</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ronco</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Naas</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Duport</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Michel-Briand</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Labia</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Characterization of a novel extended-spectrum beta-lactamase from <italic>Pseudomonas aeruginosa</italic></article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>1993</year>
          <volume>37</volume>
          <fpage>962</fpage>
          <lpage>969</lpage>
          <pub-id pub-id-type="pmid">8517722</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vahaboglu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Coskunkan</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Tansel</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Ozturk</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sahin</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Koksal</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kocazeybek</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Tatman-Otkun</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Leblebicioglu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ozinel</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Akalin</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kocagoz</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Korten</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Clinical importance of extended-spectrum beta-lactamase (PER-1-type)-producing <italic>Acinetobacter </italic>spp. and <italic>Pseudomonas aeruginosa </italic>strains</article-title>
          <source>J Med Microbiol</source>
          <year>2001</year>
          <volume>50</volume>
          <fpage>642</fpage>
          <lpage>645</lpage>
          <pub-id pub-id-type="pmid">11444775</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Queenan</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Bush</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Carbapenemases: the versatile beta-lactamases</article-title>
          <source>Clin Microbiol Rev</source>
          <year>2007</year>
          <volume>20</volume>
          <fpage>440</fpage>
          <lpage>458</lpage>
          <pub-id pub-id-type="pmid">17630334</pub-id>
          <pub-id pub-id-type="doi">10.1128/CMR.00001-07</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <collab>Clinical and Laboratory Standards Institute (CLSI)</collab>
          </person-group>
          <source>Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, Approved standard M7-A7. CLSI, Wayne, PA</source>
          <year>2006</year>
          <edition>7</edition>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grundmann</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hartung</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Daschner</surname>
              <given-names>FD</given-names>
            </name>
            <name>
              <surname>Pitt</surname>
              <given-names>TL</given-names>
            </name>
          </person-group>
          <article-title>Discriminatory power of three DNA-based typing techniques for <italic>Pseudomonas aeruginosa</italic></article-title>
          <source>J Clin Microbiol</source>
          <year>1995</year>
          <volume>33</volume>
          <fpage>528</fpage>
          <lpage>534</lpage>
          <pub-id pub-id-type="pmid">7751352</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paterson</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Rice</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Bonomo</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Rapid method of extraction and analysis of extended-spectrum beta-lactamases from clinical strains of <italic>Klebsiella pneumoniae</italic></article-title>
          <source>Clin Microbiol Infect</source>
          <year>2001</year>
          <volume>7</volume>
          <fpage>709</fpage>
          <lpage>711</lpage>
          <pub-id pub-id-type="pmid">11843918</pub-id>
          <pub-id pub-id-type="doi">10.1046/j.1469-0691.2001.00348.x</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Essack</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Pillay</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>McFadyen</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Livermore</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <article-title>Complexity and diversity of <italic>Klebsiella pneumoniae </italic>strains with extended-spectrum beta-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban, South Africa</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2001</year>
          <volume>45</volume>
          <fpage>88</fpage>
          <lpage>95</lpage>
          <pub-id pub-id-type="pmid">11120950</pub-id>
          <pub-id pub-id-type="doi">10.1128/AAC.45.1.88-95.2001</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pagani</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mantengoli</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Migliavacca</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Nucleo</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pollini</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Spalla</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Daturi</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Romero</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rossolini</surname>
              <given-names>GM</given-names>
            </name>
          </person-group>
          <article-title>Multifocal detection of multidrug-resistant <italic>Pseudomonas aeruginosa </italic>producing the PER-1 extended-spectrum beta-lactamase in Northern Italy</article-title>
          <source>J Clin Microbiol</source>
          <year>2004</year>
          <volume>42</volume>
          <fpage>2523</fpage>
          <lpage>2529</lpage>
          <pub-id pub-id-type="pmid">15184430</pub-id>
          <pub-id pub-id-type="doi">10.1128/JCM.42.6.2523-2529.2004</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bert</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Branger</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lambert-Zechovsky</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Identification of PSE and OXA beta-lactamase genes in <italic>Pseudomonas aeruginosa </italic>using PCR-restriction fragment length polymorphism</article-title>
          <source>J Antimicrob Chemother</source>
          <year>2002</year>
          <volume>50</volume>
          <fpage>11</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="pmid">12096001</pub-id>
          <pub-id pub-id-type="doi">10.1093/jac/dkf069</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Docquier</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Riccio</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Mugnaioli</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Luzzaro</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Endimiani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Toniolo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Amicosante</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Rossolini</surname>
              <given-names>GM</given-names>
            </name>
          </person-group>
          <article-title>IMP-12, a new plasmid-encoded metallo-beta-lactamase from a <italic>Pseudomonas putida </italic>clinical isolate</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2003</year>
          <volume>47</volume>
          <fpage>1522</fpage>
          <lpage>1528</lpage>
          <pub-id pub-id-type="pmid">12709317</pub-id>
          <pub-id pub-id-type="doi">10.1128/AAC.47.5.1522-1528.2003</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Toth</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gacs</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Marialigeti</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Cech</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Fuzi</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Occurrence and regional distribution of SHV-type extended-spectrum beta-lactamases in Hungary</article-title>
          <source>Eur J Clin Microbiol Infect Dis</source>
          <year>2005</year>
          <volume>24</volume>
          <fpage>284</fpage>
          <lpage>287</lpage>
          <pub-id pub-id-type="pmid">15902537</pub-id>
          <pub-id pub-id-type="doi">10.1007/s10096-005-1315-9</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Damjanova</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Toth</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Paszti</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bauernfeind</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fuzi</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Nationwide spread of clonally related CTX-M-15-producing multidrug-resistant Klebsiella pneumoniae strains in Hungary</article-title>
          <source>Eur J Clin Microbiol Infect Dis</source>
          <year>2006</year>
          <volume>25</volume>
          <fpage>275</fpage>
          <lpage>278</lpage>
          <pub-id pub-id-type="pmid">16565826</pub-id>
          <pub-id pub-id-type="doi">10.1007/s10096-006-0120-4</pub-id>
        </citation>
      </ref>
      <ref id="B15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bouchillon</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Hoban</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Dowzicky</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Visalli</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Bradford</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
          <article-title>Determining incidence of extended spectrum beta-lactamase producing <italic>Enterobacteriaceae</italic>, vancomycin-resistant <italic>Enterococcus faecium </italic>and methicillin-resistant <italic>Staphylococcus aureus </italic>in 38 centres from 17 countries: the PEARLS study 2001&#x2013;2002</article-title>
          <source>Int J Antimicrob Agents</source>
          <year>2004</year>
          <volume>24</volume>
          <fpage>119</fpage>
          <lpage>124</lpage>
          <pub-id pub-id-type="pmid">15288309</pub-id>
          <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2004.01.010</pub-id>
        </citation>
      </ref>
      <ref id="B16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mohamed Al-Agamy</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>El-Din Ashour</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Wiegand</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>First description of CTX-M beta-lactamase-producing clinical <italic>Escherichia coli </italic>isolates from Egypt</article-title>
          <source>Int J Antimicrob Agents</source>
          <year>2006</year>
          <volume>27</volume>
          <fpage>545</fpage>
          <lpage>548</lpage>
          <pub-id pub-id-type="pmid">16713187</pub-id>
          <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2006.01.007</pub-id>
        </citation>
      </ref>
      <ref id="B17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vahaboglu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ozturk</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Aygun</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Coskunkan</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Yaman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kaygusuz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Leblebicioglu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Balik</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Aydin</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Otkun</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial <italic>Acinetobacter </italic>and <italic>Pseudomonas aeruginosa </italic>isolates in Turkey: a nationwide multicenter study</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>1997</year>
          <volume>41</volume>
          <fpage>2265</fpage>
          <lpage>2269</lpage>
          <pub-id pub-id-type="pmid">9333059</pub-id>
        </citation>
      </ref>
      <ref id="B18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kolayli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Gacar</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Karadenizli</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sanic</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vahaboglu</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>PER-1 is still widespread in Turkish hospitals among <italic>Pseudomonas aeruginosa </italic>and <italic>Acinetobacter </italic>spp</article-title>
          <source>FEMS Microbiol Lett</source>
          <year>2005</year>
          <volume>249</volume>
          <fpage>241</fpage>
          <lpage>245</lpage>
          <pub-id pub-id-type="pmid">16006075</pub-id>
          <pub-id pub-id-type="doi">10.1016/j.femsle.2005.06.012</pub-id>
        </citation>
      </ref>
      <ref id="B19">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Champs</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Poirel</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bonnet</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sirot</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Chanal</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sirot</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Nordmann</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Prospective survey of beta-lactamases produced by ceftazidime- resistant <italic>Pseudomonas aeruginosa </italic>isolated in a French hospital in 2000</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2002</year>
          <volume>46</volume>
          <fpage>3031</fpage>
          <lpage>3034</lpage>
          <pub-id pub-id-type="pmid">12183264</pub-id>
          <pub-id pub-id-type="doi">10.1128/AAC.46.9.3031-3034.2002</pub-id>
        </citation>
      </ref>
      <ref id="B20">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Naas</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Bogaerts</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bauraing</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Degheldre</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Glupczynski</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nordmann</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Emergence of PER and VEB extended-spectrum beta-lactamases in <italic>Acinetobacter baumannii </italic>in Belgium</article-title>
          <source>J Antimicrob Chemother</source>
          <year>2006</year>
          <volume>58</volume>
          <fpage>178</fpage>
          <lpage>182</lpage>
          <pub-id pub-id-type="pmid">16670107</pub-id>
          <pub-id pub-id-type="doi">10.1093/jac/dkl178</pub-id>
        </citation>
      </ref>
      <ref id="B21">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miro</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Mirelis</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Navarro</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rivera</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mesa</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Roig</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Gomez</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Coll</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Surveillance of extended-spectrum beta-lactamases from clinical samples and faecal carriers in Barcelona, Spain</article-title>
          <source>J Antimicrob Chemother</source>
          <year>2005</year>
          <volume>56</volume>
          <fpage>1152</fpage>
          <lpage>1155</lpage>
          <pub-id pub-id-type="pmid">16244084</pub-id>
          <pub-id pub-id-type="doi">10.1093/jac/dki395</pub-id>
        </citation>
      </ref>
      <ref id="B22">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Empel</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Filczak</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mrowka</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hryniewicz</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Livermore</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Gniadkowski</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Outbreak of <italic>Pseudomonas aeruginosa </italic>infections with PER-1 extended-spectrum beta-lactamase in Warsaw, Poland: further evidence for an international clonal complex</article-title>
          <source>J Clin Microbiol</source>
          <year>2007</year>
          <volume>45</volume>
          <fpage>2829</fpage>
          <lpage>2834</lpage>
          <pub-id pub-id-type="pmid">17634312</pub-id>
          <pub-id pub-id-type="doi">10.1128/JCM.00997-07</pub-id>
        </citation>
      </ref>
      <ref id="B23">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Naas</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nordmann</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Heidt</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Intercountry transfer of PER-1 extended-spectrum beta-lactamase-producing <italic>Acinetobacter baumannii </italic>from Romania</article-title>
          <source>Int J Antimicrob Agents</source>
          <year>2007</year>
          <volume>29</volume>
          <fpage>226</fpage>
          <lpage>228</lpage>
          <pub-id pub-id-type="pmid">17137755</pub-id>
          <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2006.08.032</pub-id>
        </citation>
      </ref>
      <ref id="B24">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamano</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nishikawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Fujimura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yutsudou</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tsuji</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Miwa</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Occurrence of PER-1 producing clinical isolates of <italic>Pseudomonas aeruginosa </italic>in Japan and their susceptibility to doripenem</article-title>
          <source>J Antibiot (Tokyo)</source>
          <year>2006</year>
          <volume>59</volume>
          <fpage>791</fpage>
          <lpage>796</lpage>
          <pub-id pub-id-type="pmid">17323646</pub-id>
        </citation>
      </ref>
      <ref id="B25">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>HK</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>MW</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of Ambler class A and D beta-lactamases among clinical isolates of <italic>Pseudomonas aeruginosa </italic>in Korea</article-title>
          <source>J Antimicrob Chemother</source>
          <year>2005</year>
          <volume>56</volume>
          <fpage>122</fpage>
          <lpage>127</lpage>
          <pub-id pub-id-type="pmid">15890715</pub-id>
          <pub-id pub-id-type="doi">10.1093/jac/dki160</pub-id>
        </citation>
      </ref>
      <ref id="B26">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yong</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yum</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Chong</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Bauernfeind</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>High prevalence of PER-1 extended-spectrum beta-lactamase-producing <italic>Acinetobacter </italic>spp. in Korea</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2003</year>
          <volume>47</volume>
          <fpage>1749</fpage>
          <lpage>1751</lpage>
          <pub-id pub-id-type="pmid">12709353</pub-id>
          <pub-id pub-id-type="doi">10.1128/AAC.47.5.1749-1751.2003</pub-id>
        </citation>
      </ref>
      <ref id="B27">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jeong</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Bae</surname>
              <given-names>IK</given-names>
            </name>
            <name>
              <surname>Kwon</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yong</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Woo</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>HI</given-names>
            </name>
            <name>
              <surname>Jang</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Sung</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SH</given-names>
            </name>
          </person-group>
          <article-title>Investigation of a nosocomial outbreak of <italic>Acinetobacter baumannii </italic>producing PER-1 extended-spectrum beta-lactamase in an intensive care unit</article-title>
          <source>J Hosp Infect</source>
          <year>2005</year>
          <volume>59</volume>
          <fpage>242</fpage>
          <lpage>248</lpage>
          <pub-id pub-id-type="pmid">15694982</pub-id>
          <pub-id pub-id-type="doi">10.1016/j.jhin.2004.09.025</pub-id>
        </citation>
      </ref>
      <ref id="B28">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Libisch</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Lepsanovic</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Krucso</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Muzslay</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tomanovic</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Nonkovic</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Mirovic</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Szabo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Balogh</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>F&#xFC;zi</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Characterization of PER-1 extended-spectrum &#x3B2;-lactamase producing <italic>Pseudomonas aeruginosa </italic>clinical isolates from Hungary and Serbia. [poster]</article-title>
          <source>Clin Microbiol Infect</source>
          <year>2007</year>
          <volume>13</volume>
          <fpage>S162</fpage>
        </citation>
      </ref>
      <ref id="B29">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fritsche</surname>
              <given-names>TR</given-names>
            </name>
            <name>
              <surname>Sader</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Toleman</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Walsh</surname>
              <given-names>TR</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>RN</given-names>
            </name>
          </person-group>
          <article-title>Emerging metallo-beta-lactamase-mediated resistances: a summary report from the worldwide SENTRY antimicrobial surveillance program</article-title>
          <source>Clin Infect Dis</source>
          <year>2005</year>
          <volume>41</volume>
          <fpage>S276</fpage>
          <lpage>278</lpage>
          <pub-id pub-id-type="pmid">16032565</pub-id>
          <pub-id pub-id-type="doi">10.1086/430790</pub-id>
        </citation>
      </ref>
      <ref id="B30">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walsh</surname>
              <given-names>TR</given-names>
            </name>
            <name>
              <surname>Toleman</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Hryniewicz</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Bennett</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>RN</given-names>
            </name>
          </person-group>
          <article-title>Evolution of an integron carrying blaVIM-2 in Eastern Europe: report from the SENTRY Antimicrobial Surveillance Program</article-title>
          <source>J Antimicrob Chemother</source>
          <year>2003</year>
          <volume>52</volume>
          <fpage>116</fpage>
          <lpage>119</lpage>
          <pub-id pub-id-type="pmid">12805257</pub-id>
          <pub-id pub-id-type="doi">10.1093/jac/dkg299</pub-id>
        </citation>
      </ref>
      <ref id="B31">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mi</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title><italic>Pseudomonas aeruginosa </italic>producing VIM-2 metallo-beta-lactamases and carrying two aminoglycoside-modifying enzymes in China</article-title>
          <source>J Hosp Infect</source>
          <year>2006</year>
          <volume>62</volume>
          <fpage>522</fpage>
          <lpage>524</lpage>
          <pub-id pub-id-type="pmid">16448720</pub-id>
          <pub-id pub-id-type="doi">10.1016/j.jhin.2005.10.002</pub-id>
        </citation>
      </ref>
      <ref id="B32">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yan</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Ko</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Chuang</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
          <article-title>Metallo-beta-lactamase-producing <italic>Enterobacteriaceae </italic>isolates in a university hospital in Taiwan: prevalence of IMP-8 in <italic>Enterobacter cloacae </italic>and first identification of VIM-2 in <italic>Citrobacter freundii</italic></article-title>
          <source>J Antimicrob Chemother</source>
          <year>2002</year>
          <volume>50</volume>
          <fpage>503</fpage>
          <lpage>511</lpage>
          <pub-id pub-id-type="pmid">12356794</pub-id>
          <pub-id pub-id-type="doi">10.1093/jac/dkf170</pub-id>
        </citation>
      </ref>
      <ref id="B33">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>pGuerin</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Henegar</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Spiridon</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Launay</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Salmon-Ceron</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Poyart</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Bacterial prostatitis due to <italic>Pseudomonas aeruginosa </italic>harbouring the blaVIM-2 metallo-&#x3B2;-lactamase gene from Saudi Arabia</article-title>
          <source>J Antimicrob Chemother</source>
          <year>2005</year>
          <volume>56</volume>
          <fpage>601</fpage>
          <lpage>602</lpage>
          <pub-id pub-id-type="pmid">16087655</pub-id>
          <pub-id pub-id-type="doi">10.1093/jac/dki280</pub-id>
        </citation>
      </ref>
      <ref id="B34">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aboufaycal</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sader</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Rolston</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Deshpande</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Toleman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bodey</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Raad</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>RN</given-names>
            </name>
          </person-group>
          <article-title>blaVIM-2 and blaVIM-7 carbapenemase-producing <italic>Pseudomonas aeruginosa </italic>isolates detected in a tertiary care medical center in the United States: report from the MYSTIC program</article-title>
          <source>J Clin Microbiol</source>
          <year>2007</year>
          <volume>45</volume>
          <fpage>614</fpage>
          <lpage>615</lpage>
          <pub-id pub-id-type="pmid">17151207</pub-id>
          <pub-id pub-id-type="doi">10.1128/JCM.01351-06</pub-id>
        </citation>
      </ref>
      <ref id="B35">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pitout</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Chow</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Gregson</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Laupland</surname>
              <given-names>KB</given-names>
            </name>
            <name>
              <surname>Elsayed</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Church</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
          <article-title>Molecular epidemiology of metallo-beta-lactamase-producing <italic>Pseudomonas aeruginosa </italic>in the Calgary Health Region: emergence of VIM-2-producing isolates</article-title>
          <source>J Clin Microbiol</source>
          <year>2007</year>
          <volume>45</volume>
          <fpage>294</fpage>
          <lpage>298</lpage>
          <pub-id pub-id-type="pmid">17122002</pub-id>
          <pub-id pub-id-type="doi">10.1128/JCM.01694-06</pub-id>
        </citation>
      </ref>
      <ref id="B36">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Libisch</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Muzslay</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gacs</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Min&#xE1;rovits</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Knausz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Watine</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tern&#xE1;k</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ken&#xE9;z</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kustos</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>R&#xF3;kusz</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sz&#xE9;les</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Balogh</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>F&#xFC;zi</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Molecular epidemiology of VIM-4 metallo-beta-lactamase-producing <italic>Pseudomonas </italic>sp. isolates in Hungary</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2006</year>
          <volume>50</volume>
          <fpage>4220</fpage>
          <lpage>4223</lpage>
          <pub-id pub-id-type="pmid">17000739</pub-id>
          <pub-id pub-id-type="doi">10.1128/AAC.00300-06</pub-id>
        </citation>
      </ref>
      <ref id="B37">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Libisch</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Watine</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Balogh</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Gacs</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Muzslay</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Szabo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Fuzi</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Molecular typing indicates an important role for two international clonal complexes in dissemination of VIM-producing <italic>Pseudomonas aeruginosa </italic>clinical isolates in Hungary</article-title>
          <source>Res Microbiol</source>
          <year>2008</year>
          <volume>159</volume>
          <fpage>162</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">18280707</pub-id>
          <pub-id pub-id-type="doi">10.1016/j.resmic.2007.12.008</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
